RT plus anti-TIGIT combination therapy increased the number of CD8 + T cells and the percentage of IFNγ + TNFα + CD8 + T cells in tumor tissues and TdLNs in WT mice (Fig. 7d–e). The gene discussed is TIGIT; the disease is neoplasm.